Can Serum Drops Containing Doxycycline Provide a Supplemental Anti-Bacterial Effect in the Treatment of Bacterial Keratitis?
Purpose: Systemic doxycycline has been prescribed to reduce inflammation and enhance corneal healing in bacterial keratitis. Topical autologous serum drops (ASD) containing doxycycline following oral supplementation may additionally confer an anti-bacterial effect. The potential of this supplementat...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_7d3fdce2acd34d4d96da7e25dfb004dc | ||
042 | |a dc | ||
100 | 1 | 0 | |a David Mora-Boellstorff |e author |
700 | 1 | 0 | |a Kanwal Matharu |e author |
700 | 1 | 0 | |a Vishal Jhanji |e author |
700 | 1 | 0 | |a Regis P. Kowalski |e author |
245 | 0 | 0 | |a Can Serum Drops Containing Doxycycline Provide a Supplemental Anti-Bacterial Effect in the Treatment of Bacterial Keratitis? |
260 | |b MDPI AG, |c 2023-07-01T00:00:00Z. | ||
500 | |a 10.3390/antibiotics12071145 | ||
500 | |a 2079-6382 | ||
520 | |a Purpose: Systemic doxycycline has been prescribed to reduce inflammation and enhance corneal healing in bacterial keratitis. Topical autologous serum drops (ASD) containing doxycycline following oral supplementation may additionally confer an anti-bacterial effect. The potential of this supplementation was evaluated by determining the in vitro susceptibility of bacterial keratitis isolates to doxycycline. Methods: The minimum inhibitory concentrations (MICs) of doxycycline against 100 bacterial keratitis isolates were determined using Etests. Twenty-seven <i>Staphylococcus aureus</i>, ten coagulase-negative <i>Staphylococci</i>, six <i>Streptococcus pneumoniae</i>, seven viridans group streptococci, seven other Gram-positive bacteria, nineteen <i>Pseudomonas aeruginosa</i>, eight <i>Serratia marcescens</i>, four <i>Moraxella</i> spp., two <i>Haemophilus</i> spp., and ten other Gram-negative bacteria isolates were tested. MICs of doxycycline were compared to a serum standard concentration of doxycycline (SSCD) of 4 µg/mL and concentrations that would be found in 50% and 20% serum component clinical preparations of ASD, corresponding to 50% SSCD (2 µg/mL) and 20% SSCD (0.8 µg/mL), respectively. MICs equal to or less than these values were used to deem a bacterial isolate susceptible. Results: For Gram-positive bacteria, susceptibilities to SSCD, 50% SSCD, and 20% SSCD were 86%, 65%, and 60%, respectively. For Gram-negative bacteria, susceptibilities to SSCD, 50% SSCD, and 20% SSCD were 37.2%, 23.3%, and 11.6%, respectively. Chi-squared analyses comparing Gram-positive and Gram-negative susceptibilities showed significantly greater susceptibility of Gram-positive bacteria at all three tested MICs (<0.0001, <0.0001, <0.0001). Conclusions: Our data suggest that autologous serum drops containing theoretic concentrations of doxycycline may provide an additional anti-bacterial effect in the treatment of bacterial keratitis, especially for Gram-positive bacterial keratitis compared to Gram-negative bacterial keratitis. | ||
546 | |a EN | ||
690 | |a doxycycline | ||
690 | |a bacterial keratitis | ||
690 | |a autologous serum drops | ||
690 | |a susceptibility | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Antibiotics, Vol 12, Iss 7, p 1145 (2023) | |
787 | 0 | |n https://www.mdpi.com/2079-6382/12/7/1145 | |
787 | 0 | |n https://doaj.org/toc/2079-6382 | |
856 | 4 | 1 | |u https://doaj.org/article/7d3fdce2acd34d4d96da7e25dfb004dc |z Connect to this object online. |